Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema

Figure 3

Changes in the mean BCVA (logMAR units) and CMT relative to the baseline with and without a previous STTA treatment. In eyes refractory to STTA, the IVR significantly improves the BCVA at 3 and 6 months after the IVR treatment. STTA, sub-Tenon’s triamcinolone acetonide; CMT, central macular thickness; Data are expressed as mean ± SEM. ; relative to the baseline of the BCVA and the CMT.